Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Current Assets (2024 - 2025)

Carlsmed (CARL) has disclosed Current Assets for 2 consecutive years, with $126.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets rose 156.68% year-over-year to $126.7 million, compared with a TTM value of $126.7 million through Dec 2025, up 156.68%, and an annual FY2025 reading of $126.7 million, up 156.68% over the prior year.
  • Current Assets was $126.7 million for Q4 2025 at Carlsmed, down from $131.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $131.5 million in Q3 2025 and bottomed at $46.2 million in Q2 2025.